Resultados da pesquisa - Arlene Reisman
- A mostrar 1 - 7 resultados de 7
-
1
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidi... Por Daniel H. Kett, Andrew F. Shorr, Annette C. Reboli, Arlene Reisman, Pinaki Biswas, Haran T. Schlamm
Publicado em 2011Artigo -
2
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study Por Richard G. Wunderink, Michael S. Niederman, Marin H. Kollef, Andrew F. Shorr, M Künkel, Alice Baruch, William T. McGee, Arlene Reisman, Jean Chastre
Publicado em 2012Artigo -
3
Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced... Por Fiona Blackhall, Dong‐Wan Kim, Benjamin Besse, Hiroshi Nokihara, Ji‐Youn Han, Keith D. Wilner, Arlene Reisman, Shrividya Iyer, Vera Hirsh, Alice T. Shaw
Publicado em 2014Artigo -
4
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associate... Por Annette C. Reboli, Andrew F. Shorr, Coleman Rotstein, Peter G. Pappas, Daniel H. Kett, Haran T. Schlamm, Arlene Reisman, Pinaki Biswas, Thomas J. Walsh
Publicado em 2011Artigo -
5
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study Por Stephen J. Freedland, John P. Mulhall, Martin Gleave, Ugo De Giorgi, Fred Saad, Antti Rannikko, Jasmina Ivanova, Anchen F. Nasr, Arlene Reisman, Arijit Ganguli, Pavol Kráľ, James Turnbull, Neal D. Shore
Publicado em 2025Artigo -
6
First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer Por Benjamin Solomon, Tony Mok, Dong‐Wan Kim, Yi‐Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari, Shrividya Iyer, Arlene Reisman, Keith D. Wilner, Jennifer Tursi, Fiona Blackhall
Publicado em 2014Artigo -
7
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-... Por Fiona Blackhall, D. Ross Camidge, Alice T. Shaw, Jean‐Charles Soria, Benjamin Solomon, Tony Mok, Vera Hirsh, Pasi A. Jänne, Yuankai Shi, Pan‐Chyr Yang, Tommaso De Pas, Toyoaki Hida, Javier de Castro, Silvana Lanzalone, Anna Polli, Shrividya Iyer, Arlene Reisman, Keith D. Wilner, Dong‐Wan Kim
Publicado em 2017Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Oncology
Crizotinib
Lung cancer
Malignant pleural effusion
ALK inhibitor
Anidulafungin
Antifungal
Biology
Caspofungin
Chemotherapy
Echinocandin
Echinocandins
Environmental health
Fluconazole
Intensive care medicine
Invasive candidiasis
Microbiology
Population
Adverse effect
Anaplastic lymphoma kinase
Androgen receptor
Antibacterial agent
Antibiotics
Bacteria
Cancer
Candida albicans
Cisplatin
Clinical trial